UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002573
Receipt number R000003134
Scientific Title Multicenter Prospective Randomized Study of First-choice Guidewires in Percutaneous Coronary Intervention for Chronic Total Occlusion
Date of disclosure of the study information 2009/10/01
Last modified on 2015/05/11 13:07:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter Prospective Randomized Study of First-choice Guidewires in Percutaneous Coronary Intervention for Chronic Total Occlusion

Acronym

G-FORCE

Scientific Title

Multicenter Prospective Randomized Study of First-choice Guidewires in Percutaneous Coronary Intervention for Chronic Total Occlusion

Scientific Title:Acronym

G-FORCE

Region

Japan


Condition

Condition

Patients undergoing Percutaneous Coronary Intervention (PCI) for chronic total occlusion (CTO)

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Under the circumstances that appropriate first-choice guidewires for percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) have yet to be established, the objective of this study is to determine appropriate first-choice guidewires.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase IV


Assessment

Primary outcomes

Lesion penetration rate of a first-choice guidewire

Key secondary outcomes

Successful PCI rate
Definition of successful PCI: The target lesion is successfully dilated without any major cardiovascular events.
Types of guidewires successfully passing through the lesion
Usage rate and success rate of the retrograde approach
Usage rate and success rate of the parallel wire technique
Usage rate and success rate of IVUS assistance
Usage rate and success rate of coronary CT
Total death
Cardiac death
Myocardial infarction (MI) (Q-wave/non-Q-wave)
Emergency surgeries (CABG/other)
Major adverse cardio-cerebral events (MACCEs: total death, MI, stroke, and all revascularization procedures)
Stroke
Guidewire-induced perforation
Cardiac tamponade
Hemorrhagic complications
Puncture site complications
Sizes and types of guiding catheters
Approach sites
Total number of guidewires used
Total number of guiding catheters used
Total number of CTO treated cases during the enrollment period


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Primary guidewire is normal size (distal tip = 0.014 inch)

Interventions/Control_2

Primary guidewire is slender size (dista tip equal to or less than 0.010inch)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with a PCI-treatable CTO lesion in a main vessel of the coronary arteries
Patients with a de novo CTO lesion
Patients undergoing an elective PCI procedure
Patients who provide informed consent

Key exclusion criteria

Patients for whom PCI is not indicated
Patients with the same CTO previously treated with PCI without success
Patients with restenosis or in-stent restenosis
Patients with a venous or arterial graft
Patients under 21 years old
Women of child-bearing potential
Patients who do not provide informed consent

Target sample size

290


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuji Ikari

Organization

Tokai University School of Medicine

Division name

Cardiology

Zip code


Address

143, Shimokasuya, Isehara, Kanagawa, Japan

TEL

0463-63-1121

Email

ikari@is.icc.u-tokai.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Chie Kato

Organization

Tokai University School of Medicine

Division name

Cardiology

Zip code


Address

143, Shimokasuya, Isehara, Kanagawa, Japan

TEL

0463-63-1121

Homepage URL


Email

tokai-rinsho@ml.u-tokai.ac.jp


Sponsor or person

Institute

Tokai University

Institute

Department

Personal name



Funding Source

Organization

Kaneka Medics
Terumo
Japan Lifeline
Asahi Intech
Abbott Vascular

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

NCT00987610

Org. issuing International ID_1

ClinicalTrials.gov

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 09 Month 19 Day

Date of IRB


Anticipated trial start date

2009 Year 10 Month 01 Day

Last follow-up date

2011 Year 09 Month 01 Day

Date of closure to data entry

2011 Year 09 Month 01 Day

Date trial data considered complete

2014 Year 12 Month 31 Day

Date analysis concluded

2015 Year 07 Month 15 Day


Other

Other related information



Management information

Registered date

2009 Year 10 Month 01 Day

Last modified on

2015 Year 05 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003134